Literature DB >> 8709089

Cavernous haemangioma with Kasabach-Merritt syndrome: treatment with alpha-interferon.

J J Ettlinger1, P J Fleming, H S Joffe, C T Kennedy.   

Abstract

A small number of patients with haemangioma need treatment for serious complications such as Kasabach-Merritt syndrome, cardiac failure and obstruction of the airway. We report on the management of an infant with Kasabach-Merritt syndrome.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8709089      PMCID： PMC1295647          DOI： 10.1177/014107689608900117

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


  8 in total

1.  Treatment of haemangioendotheliomas with alpha interferon.

Authors:  P J Orchard; C M Smith; W G Woods; D L Day; L P Dehner; R Shapiro
Journal:  Lancet       Date:  1989-09-02       Impact factor: 79.321

2.  Treatment of pulmonary hemangiomatosis with recombinant interferon alfa-2a.

Authors:  C W White; H M Sondheimer; E C Crouch; H Wilson; L L Fan
Journal:  N Engl J Med       Date:  1989-05-04       Impact factor: 91.245

3.  Management of alarming hemangiomas in infancy: a review of 25 cases.

Authors:  O Enjolras; M C Riche; J J Merland; J P Escande
Journal:  Pediatrics       Date:  1990-04       Impact factor: 7.124

4.  Serious childhood angiomas: unsuccessful alpha-2b interferon treatment. A report of four cases.

Authors:  D Teillac-Hamel; Y De Prost; C Bodemer; P Andry; O Enjolras; G Sebag; F Brunelle; P Hubert; C Nihoul-Fekete
Journal:  Br J Dermatol       Date:  1993-10       Impact factor: 9.302

5.  Hypertrophic obstructive cardiomyopathy as a side effect of dexamethasone treatment for bronchopulmonary dysplasia.

Authors:  P L Brand; R A van Lingen; F Brus; M D Talsma; N J Elzenga
Journal:  Acta Paediatr       Date:  1993 Jun-Jul       Impact factor: 2.299

6.  Treatment of childhood angiomatous diseases with recombinant interferon alfa-2a.

Authors:  C W White; S J Wolf; D N Korones; H M Sondheimer; M F Tosi; A Yu
Journal:  J Pediatr       Date:  1991-01       Impact factor: 4.406

7.  Interferon alfa-2a therapy for life-threatening hemangiomas of infancy.

Authors:  R A Ezekowitz; J B Mulliken; J Folkman
Journal:  N Engl J Med       Date:  1992-05-28       Impact factor: 91.245

8.  Cardiovascular effects of dexamethasone in the preterm infant.

Authors:  N Evans
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-01       Impact factor: 5.747
  8 in total
  1 in total

1.  Long-term outcomes of low-dose radiotherapy in Kasabach-Merritt syndrome.

Authors:  Dowook Kim; Jung Yoon Choi; Kyung Taek Hong; Hyoung Jin Kang; Il Han Kim; Joo Ho Lee
Journal:  Radiat Oncol J       Date:  2022-03-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.